267 related articles for article (PubMed ID: 36064986)
1. Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery.
Traeger L; Hall TD; Bedrikovetski S; Kroon HM; Dudi-Venkata NN; Moore JW; Sammour T
Tech Coloproctol; 2023 Mar; 27(3):217-226. PubMed ID: 36064986
[TBL] [Abstract][Full Text] [Related]
2. Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients.
Hunt ME; Yates JR; Vega H; Heidel RE; Buehler JM
Ann Pharmacother; 2020 Dec; 54(12):1165-1174. PubMed ID: 32468846
[TBL] [Abstract][Full Text] [Related]
3. Sugammadex reversal of muscle relaxant blockade provided less Post-Anesthesia Care Unit adverse effects than neostigmine/glycopyrrolate.
Chang HC; Liu SY; Lee MJ; Lee SO; Wong CS
J Formos Med Assoc; 2022 Dec; 121(12):2639-2643. PubMed ID: 35577643
[TBL] [Abstract][Full Text] [Related]
4. Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.
Bash LD; Turzhitsky V; Mark RJ; Hofer IS; Weingarten TN
J Clin Anesth; 2024 May; 93():111344. PubMed ID: 38007845
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
6. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
[TBL] [Abstract][Full Text] [Related]
7. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
[TBL] [Abstract][Full Text] [Related]
9. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
Paech MJ; Kaye R; Baber C; Nathan EA
Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
[TBL] [Abstract][Full Text] [Related]
10. Effects of Reversal Technique for Neuromuscular Paralysis on Time to Recovery of Bowel Function after Craniotomy.
Deljou A; Soleimani J; Sprung J; Schroeder DR; Weingarten TN
Am Surg; 2023 May; 89(5):1605-1609. PubMed ID: 34986061
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blockade reversal with sugammadex versus pyridostigmine/glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility.
An J; Noh H; Kim E; Lee J; Woo K; Kim H
Korean J Anesthesiol; 2020 Apr; 73(2):137-144. PubMed ID: 31636242
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
Togioka BM; Schenning KJ
Drugs Aging; 2022 Oct; 39(10):749-761. PubMed ID: 35934764
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
15. Rocuronium Reversal in the Emergency Department: Retrospective Evaluation of Hemodynamic Instability Following Administration of Sugammadex Versus Neostigmine With Glycopyrrolate.
Hile GB; Healy KJ; Almassalkhi LR
J Pharm Pract; 2023 Apr; 36(2):336-341. PubMed ID: 34601981
[No Abstract] [Full Text] [Related]
16. The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex.
Oh TK; Ji E; Na HS
Medicine (Baltimore); 2019 Jun; 98(26):e16142. PubMed ID: 31261539
[TBL] [Abstract][Full Text] [Related]
17. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex and urinary retention after hysterectomy: A propensity-matched cohort study.
De Lima Laporta Miranda ML; Ochs Kinney MA; Bakkum-Gamez JN; Schroeder DR; Sprung J; Weingarten TN
Biomol Biomed; 2024 Mar; 24(2):395-400. PubMed ID: 37715536
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
